Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company. GSK remains remain the majority shareholder in ViiV, which the pharmaceutical giant formed in partnership with Pfizer in 2009.
The post Pfizer Pockets $1.9B by Offloading Stake in HIV Drugs Company Majority-Owned by GSK appeared first on MedCity News.
